Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05902351 · ClinicalTrials.gov registry record
Natural History Study for Charcot Marie Tooth Disease
A clinical trial of Charcot Marie Tooth Disease and Charcot-Marie-Tooth, sponsored by Hereditary Neuropathy Foundation.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT05902351: Recruiting study of Charcot Marie Tooth Disease and Charcot-Marie-Tooth, sponsored by Hereditary Neuropathy Foundation.
NCT05902351 is a study of Charcot Marie Tooth Disease and Charcot-Marie-Tooth that is actively recruiting participants, run by Hereditary Neuropathy Foundation. The registered enrollment target is 10,000 participants, above the 937-participant average among 7 other Charcot Marie Tooth Disease trials with a reported enrollment target (967% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05902351, a study of Charcot Marie Tooth Disease and Charcot-Marie-Tooth, is actively recruiting participants, sponsored by Hereditary Neuropathy Foundation.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this Natural History Study for Charcot-Marie-Tooth is to acquire, record, and analyze patient-reported data and associated genetic reports, Electronic Health Records (EHRs) and clinical notes to identify the burden, diagnostic journey, and prevalence of disease that will aid scientists in their work toward finding a cure. Participants will be asked to complete a Natural History Survey.
Primary Outcome
Patient-Reported Outcomes depending on individual experience I.e. Genetic testing, clinical observation, EMG, family history.
Conditions Studied
Study Locations (1)
New York
- Hereditary Neuropathy Foundation - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2013-11-01 |
| Est. Completion | 2029-12-31 |
What NCT05902351 shows while recruiting
NCT05902351 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 937-participant average among 7 other Charcot Marie Tooth Disease trials with a reported enrollment target (967% higher).
The record links to 10 conditions, with Charcot Marie Tooth Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05902351 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05902351 about?
NCT05902351 is a clinical study titled "Natural History Study for Charcot Marie Tooth Disease". The goal of this Natural History Study for Charcot-Marie-Tooth is to acquire, record, and analyze patient-reported data and associated genetic reports, Electronic Health Records (EHRs) and clinical notes to identify the burden, diagnostic journey, and prevalence of disease that will aid scientists i...
What is the current status of trial NCT05902351?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2013-11-01. Estimated completion is 2029-12-31.
What conditions does trial NCT05902351 study?
This clinical trial studies the following conditions: Charcot Marie Tooth Disease, Charcot-Marie-Tooth, Charcot-Marie-Tooth Disease, Type IA, Charcot-Marie-Tooth Disease Type 2A, Charcot-Marie-Tooth Disease Type 2.
Who is sponsoring clinical trial NCT05902351?
This trial is sponsored by Hereditary Neuropathy Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05902351 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Charcot Marie Tooth Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
RECRUITING
-
Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for IPSC Generation and Biobanking
RECRUITING
-
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients
ACTIVE NOT RECRUITING · Phase 3
-
Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)
COMPLETED
-
Observational Study of Neuromuscular Function in CMT Type 1&2 and Healthy Controls
COMPLETED
-
Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI